Navigation Links
Expert Panel Sets Limits on Pesticide Residues in Soft Drinks

An expert panel has recommended a maximum residue limit (MRL) of one part per billion in soft drinks.//

In its report the panel has suggested that the limit should be enforced through legislation in order to ensure consumer safety.

The panel is headed by the chairman of the Indian Council of Medical Research N K Ganguly. The Ministry of Health and Family Welfare constituted it in November 2004, in the wake of a controversy over pesticide residues in colas.

The Indian Center for Science and Environment (CSE) had published a report claiming that its findings revealed high levels of pesticides in Coca-Cola and Pepsi. The levels were 24 times higher than allowed by the European Union (EU) standards. Both companies have strongly disputed the report.

The Ganguly panel’s report has been submitted to the Indian Supreme Court, which is hearing the issue of pesticides in colas.

Stating that its report was in line with the recommendations of the Joint Parliamentary Committee (JPC) on the matter, the expert panel warned that higher consumption of colas could lead to numerous ailments including weakening of bones, formation of kidney stones, osteoporosis and childhood obesity.

In a related development the Supreme Court has refused to grant any interim relief to the Kerala government, which had challenged the Kerala High Court's ruling against the ban imposed on sale of Pepsi and Coca-Cola in the state. However, the Court issued notices to Pepsico India Holdings Ltd and Hindustan Coca-Cola Pvt Ltd and asked them to file replies in four weeks.

The Kerala government had in August 2006 notified the ban on the colas but within a month the Kerala High Court set aside the ban, saying it had no right to prohibit manufacture and sale of colas.
'"/>




Page: 1

Related medicine news :

1. Good carb, bad carb? Experts debate.
2. Spread Of Rocky Mountain Spotted Fever Is A Probability, Say Experts
3. Experts Recommend Preventive Measures For Avian Flu To Begin From Farms
4. Experts Insist That Neonatal Herpes Be Reported Regularly
5. Experts State Strategies To Increase Good Cholesterol
6. Weight-Loss Medication Evaluated By Nutrition Expert
7. Cancer Can Recur Any Time, Experts Caution
8. Experts Building Bird Flu Warning System
9. Drinking Laws Fuel Disease In UK: Expert
10. Human Growth Hormone (HGH) - View of Experts
11. Chinese Poultry Vaccine Could Be Sub-Standard: Expert
Post Your Comments:
(Date:10/10/2008)...Coach Holly Warlick Teams Up with Legal and Medica...Ever Cancer and Careers Seminar in,Knoxville, KNO...ion of National,Breast Cancer Awareness Month, Can...e joined forces with YWCA Knoxville, The Wellness ...e Holly Warlick, University of Tennessee,women,s b...
(Date:10/10/2008)... The Healthcare Technology Ev... , Exton, PA (PRWEB) Sept...ey Chapters of the national Healthcare Information...forces to bring regional health information techno... conference entitled The Healthcare Technology Evo...
(Date:10/10/2008)...ston, MABoston Medical Center (BMC) has received a...l Institute on Aging (NIA) to fund the Boston Clau...BMC,s Pepper Center is one of only 11 Pepper Cente... Americans Independence Center Program was establi...enator from Florida. During his five decades of pu...
(Date:10/10/2008)...olecular CT adds metabolic information from PET to...gnostic imaging for maximized workflow ...ICH, Germany, Oct. 10 /PRNewswire/ -- Siemens Heal...duces molecular CT, a new concept in,integrated im...d is a,practical solution for today,s shrinking he...
Breaking Medicine News(10 mins):Health News:Local Experts Help Women Living and Working with Cancer Even the Score 2Health News:Local Experts Help Women Living and Working with Cancer Even the Score 3Health News:Local Experts Help Women Living and Working with Cancer Even the Score 4Health News:HIMSS New Jersey and Delaware Valley Chapters Sponsor Regional Conference 2Health News:Boston Medical Center receives $5.8m grant 2Health News:Siemens Shapes the Future of Integrated Diagnostic Imaging 2Health News:Siemens Shapes the Future of Integrated Diagnostic Imaging 3Health News:Siemens Shapes the Future of Integrated Diagnostic Imaging 4
...e world's leading pharmaceutical companies, issued...improves survival in patients// with metastatic pr...TAX 327 compared Taxotere plus prednisone to Novan...The study included a little over a thousand men wh...
...of malaria, one of the most common vector-borne di...ases in 2005 to 1.2 million cases in 2006, the Eco...ial sectors, the Economic Survey said malaria deat...o 961 people in the country in this period. Accor...
...r-pregnancy pounds should add daily walks and limi... by Harvard researchers. // “The childbearing year... women,” said lead author Emily Oken, M.D. “Modifi...m period — such as diet, television viewing and wa...
...oles in their eardrums could have better success r...ctors at West Virginia University. // The study wa...ngology – Head and Neck Surgery, the official jour...ngology-Head and Neck Surgery Foundation. Conducte...
Other Medicine News:Health News:Incidence of Malaria Has Come Down, Says Economic Survey 2Health News:Simple Solutions to Postpartum Weight Retention 2Health News:Inner-ear Volume Study Leads to Higher Surgery Success Rates 2
(Date:10/9/2008)... Top Line Clinical Results Expected in Novembe...all/ -- SCOLR Pharma, Inc.,(Amex: DDD ) announced...sing,for the third of its three pivotal trials to ...n of 12-hour extended-release (ER) ibuprofen for,t...cts to report top-line,results from this pivotal t...
(Date:10/8/2008)... - Findings May Someday Inform Treatments for ..., Oct. 8 /PRNewswire-USNewswire/ -- A protein that...r plays a key role in controlling,the developing n...s precise,connections to form among nerve cells ma...ents who suffer injuries to their nervous system,...
(Date:10/8/2008)... Findings Confirm Potency of Poly-ICR as...FirstCall/ -- Nventa Biopharmaceuticals,Corporatio...eclinical,studies using its proprietary Toll-like ...R), at the World Vaccine Congress 2008 in Lyon, Fr...potent vaccine adjuvant,targeting the Toll-like Re...
(Date:10/7/2008)... Study evaluates the efficacy of new device for de...issed during colonoscopy, ORLANDO, Fla., Oct. 7 /...terology Annual Scientific Meeting in Orlando (ACG..., MD presented results from a,multi-institutional ...Third,Eye(R) Retroscope(R), a new device that is d...
Breaking Medicine Technology:SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 2SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 3Protein Shown to Play a Key Role in Normal Development of Nervous System 2Protein Shown to Play a Key Role in Normal Development of Nervous System 3Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 2Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 3Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 4Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 5National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 2National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 3National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 4National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 5A South Florida Premiere 22160 1A South Florida Premiere 22160 2Nuvelo to Present at Jefferies 2nd Annual Healthcare Conference 22157 1Accuray Incorporateds CEO to Speak at Jefferies Second Annual Healthcare Conference 22154 1Accuray Incorporateds CEO to Speak at Jefferies Second Annual Healthcare Conference 22154 2BioSpace Launches EuroBio 28TM 29 Online Community 6074 1BioSpace Launches EuroBio 28TM 29 Online Community 6074 2
...also show evidence of additional protection,agains... LOS ANGELES, April 17, 2007 /PRNewswire-FirstCall... vaccine, CERVARIX(R),demonstrated 100 percent ef...ancer-causing human papillomavirus types 16 and 18...l, according to,data presented today at the Americ...
...USINESS WIRE)--Apr 17, 2007 - Adnexus(TM),Therapeu... abstract,"CT-322: A specific VEGFR-2-blocking pro...l tumor models comparable to pan-specific,tyrosine...b" at the,American Association for Cancer Research...e lead author is Irvith Carvajal, Ph.D., with,Eric...
Other Medicine Technology:Cervarix, GSK Cervical Cancer Candidate Vaccine, Demonstrates 100,Percent Protection Against Precancerous Lesions Caused By,Cancer-Causing Human Papillomavirus Types 16 & 18 for More Than,Five Years 2Cervarix, GSK Cervical Cancer Candidate Vaccine, Demonstrates 100,Percent Protection Against Precancerous Lesions Caused By,Cancer-Causing Human Papillomavirus Types 16 & 18 for More Than,Five Years 3Cervarix, GSK Cervical Cancer Candidate Vaccine, Demonstrates 100,Percent Protection Against Precancerous Lesions Caused By,Cancer-Causing Human Papillomavirus Types 16 & 18 for More Than,Five Years 4Cervarix, GSK Cervical Cancer Candidate Vaccine, Demonstrates 100,Percent Protection Against Precancerous Lesions Caused By,Cancer-Causing Human Papillomavirus Types 16 & 18 for More Than,Five Years 5Adnexus Therapeutics Announces Presentation at the American,Association for Cancer Research (AACR) on Clinical Product,Candidate, CT-322 2Adnexus Therapeutics Announces Presentation at the American,Association for Cancer Research (AACR) on Clinical Product,Candidate, CT-322 3Adnexus Therapeutics Announces Presentation at the American,Association for Cancer Research (AACR) on Clinical Product,Candidate, CT-322 4
Attain Left-heart Lead Delivery Systems. Medtronic offers left-heart lead delivery systems to assist with accessing the coronary sinus (cs).
Attain LV Leads. Navigate minimally angled veins with little to moderate tortuosity.
The Hancock Standard Mitral bioprosthesis is a portrait of dependability, with predictable results based on 25 years of clinical use. Documented long-term performance makes it an excellent choice for
Implantable defibrillators are used to treat heart rhythms that are abnormally fast and life threatening. Implantable cardioverter defibrillators (ICDs) often are used to treat sudden cardiac death (
Medicine Products: